Skip to main content

Arabella

Analyst

H.C. Wainwright

Equibles does not estimate personal net worth.

About Arabella

Arabella is recorded as Analyst at H.C. Wainwright. Arabella has spoken on 2 earnings calls across 2 companies, most recently for Vir Biotechnology, Inc. on August 5, 2026. Those appearances were for Vir Biotechnology, Inc. (VIR) and Definium Therapeutics, Inc. (DFTX). The companies whose calls Arabella spoke on are classified in the Healthcare sector.

Arabella on recent calls

“I guess given the field in HDV kind of shift towards focusing on TND more, I was wondering if the FDA has shared their view on TND alone versus TND plus alt-normalization.”
Analyst — H.C. Wainwright, Vir Biotechnology Second Quarter 2026 Corporate Update and Financial Results Conference Call ·
“We're looking forward to the upcoming readout. Since Panorama also includes European sites, are there any meaningful differences in diagnostic practice, placebo behavior, or standard of care that could introduce additional variability?”
Analyst — H.C. Wainwright, Definium Therapeutics, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • H.C. Wainwright

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity